Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
Jordan R. Barrett,Sandra Belij-Rammerstorfer,Christina Dold,Katie J. Ewer,Pedro M. Folegatti,Ciaran Gilbride,Rachel Halkerston,Jennifer Hill,Daniel Jenkin,Lisa Stockdale,Marije K. Verheul,Parvinder K. Aley,Brian Angus,Duncan Bellamy,Eleanor Berrie,Sagida Bibi,Mustapha Bittaye,Miles W. Carroll,Breeze Cavell,Elizabeth A. Clutterbuck,Nick Edwards,Amy Flaxman,Michelle Fuskova,Andrew Gorringe,Bassam Hallis,Simon Kerridge,Alison M. Lawrie,Aline Linder,Xinxue Liu,Meera Madhavan,Rebecca Makinson,Jack Mellors,Angela Minassian,Maria Moore,Yama Mujadidi,Emma Plested,Ian Poulton,Maheshi N. Ramasamy,Hannah Robinson, Christine S. Rollier,Rinn Song,Matthew D. Snape,Richard Tarrant,Stephen Taylor,Kelly M. Thomas,Merryn Voysey,Marion E. E. Watson,Daniel Wright,Alexander D. Douglas,Catherine M. Green,Adrian V. S. Hill,Teresa Lambe,Sarah Gilbert,Andrew J. Pollard,Jeremy Aboagye Nature Medicine(2021)
摘要
Correction to this paper has been published: https://doi.org/10.1038/s41591-021-01372-z.
更多查看译文
AI 理解论文
溯源树
样例